Peer-reviewedCC BYEuropean journal of clinical investigation1 Oct 2026

Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review

Yongxin Ye¹
Martina Colombo²
Jennifer Meessen²
Benoit Tyl³
Deborah Novelli²
Negin Hajizadeh⁴
Hans‐Peter Brunner‐La Rocca⁵
Adriaan Voors⁶
Sara Klas⁷
Stephan Schwers⁸
Bjarke Follin¹
Roberto Latini²

8 affiliations

¹Novo Nordisk A/S
²Istituto di Ricerche Farmacologiche Mario Negri IRCCS
³Bayer HealthCare SAS
⁴Bayer Espana AG
⁵Maastricht University
⁶University of Groningen
⁷Evotec International, GmbH
⁸Bayer AG

Read full text PDF Cite

Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
Yuhong Gao, Xiulin Dong, Sijia Hua +3
EBioMedicine1 Oct 2026Peer-reviewedCC BY-NCFull textOncologyEurope PMCCrossref
Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets
N. Bagherlou, S. Aliyari, Z. Salehi +2
bioRxiv30 Aug 2026PreprintAll rights reservedFull textOncologybioRxiv
Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review
Wei Yong Sheng, Tian Sheng Tang, You Shi Wu +3
Cardiology research24 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories
Xiaocheng Ding, Peng Bao, Xiaopeng Huang +5
Frontiers in Microbiology20 Oct 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
Artificial Intelligence in Gastroenterology: Towards Explainable, Generalisable and Clinically Actionable Decision Support.
İsmail Baydili, Burak Tasci, Sengul Dogan +1
Diagnostics (Basel, Switzerland)30 Sep 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC

Cite

BibTeX RIS

BibTeX

@article{ye2026circulating,
  title = {{Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review}},
  author = {Yongxin Ye and Martina Colombo and Jennifer Meessen and Benoit Tyl and Deborah Novelli and Negin Hajizadeh and Hans‐Peter Brunner‐La Rocca and Adriaan Voors and Sara Klas and Stephan Schwers and Bjarke Follin and Roberto Latini},
  journal = {European journal of clinical investigation},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13675830},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review
AU  - Yongxin Ye
AU  - Martina Colombo
AU  - Jennifer Meessen
AU  - Benoit Tyl
AU  - Deborah Novelli
AU  - Negin Hajizadeh
AU  - Hans‐Peter Brunner‐La Rocca
AU  - Adriaan Voors
AU  - Sara Klas
AU  - Stephan Schwers
AU  - Bjarke Follin
AU  - Roberto Latini
PY  - 2026
DA  - 2026/10/01
JO  - European journal of clinical investigation
UR  - https://europepmc.org/article/PMC/PMC13675830
SN  - 0014-2972
SN  - 1365-2362
ER  -

Related

Cite